Key Highlights

  • Wide Open Agriculture and Univar Solutions China have extended their exclusive offtake and distribution agreement for lupin protein products in mainland China to 31 December 2028
  • Univar must purchase a minimum of 50 tonnes of lupin protein isolate within 12 months of commercial Supply becoming available, with the clock starting when WOA formally notifies Univar of supply readiness
  • The agreement carries no immediate financial impact, with Revenue only arising once contract Manufacturing is secured and commercial supply is restored
  • WOA is progressing framework agreements with four prospective contract manufacturing partners, with the objective of appointing a preferred long-term manufacturer

Wide Open Agriculture Ltd (ASX:WOA) has announced the extension of its offtake and distribution agreement with Univar Solutions China, preserving an exclusive commercial arrangement in mainland China through to 31 December 2028. The original agreement, announced in April 2025, appointed Univar as the exclusive distributor of WOA's lupin protein products in mainland China, requiring a minimum purchase of 50 tonnes of lupin protein isolate over a 12-month period.

The extension has become necessary because WOA's German manufacturing Facility has been wound down as the company transitions to a contract manufacturing model, meaning commercial product has not been available to Univar within the original timeframe. Rather than allow the agreement to lapse, both parties have agreed to extend the term and preserve the commercial structure while WOA completes its manufacturing transition.

The Manufacturing Transition Is the Critical Variable

The agreement's commercial value is conditional on WOA restoring supply. The 50-tonne minimum purchase obligation, which is the condition for Univar maintaining its exclusive distribution rights, will only commence from the date WOA formally notifies Univar in writing that commercial quantities of product are available. The agreement does not obligate WOA to commence supply by any specified date, which gives the company flexibility but also means the timeline to first revenue under this arrangement remains open-ended.

WOA is currently progressing framework agreements with four prospective contract manufacturing partners, following announcements in August and September 2026. The company has framed the selection of a preferred long-term manufacturing partner as its immediate operational priority. Chief Executive Craig Swan has noted that Univar continues to provide market intelligence supporting the attractiveness of lupin protein in China's beverage and nutrition segments, and that the priority is to complete the partner selection and restore supply as soon as possible.

Univar's Commercial Position

Univar Solutions China is the Chinese division of Univar Solutions Inc., ranked the world's third largest chemical and ingredient distributor with US$11.5 billion in sales in 2025. The Shanghai-headquartered entity serves customers across food and nutrition, personal care, pharmaceuticals and advanced materials throughout mainland China. Since the original agreement was signed, Univar has completed customer trials and confirmed its commercial rollout strategy for China, meaning the distribution infrastructure and market development work has been done. The maintenance of Univar's Marketing commitments throughout the extended period — including customer engagement, market development and product application trials — means the China market position is being actively maintained even in the absence of commercial supply.

Under the extended agreement, if Univar materially fails to meet its marketing commitments, WOA retains the right, following 30 days written notice and an opportunity to remedy, to convert the distribution right from exclusive to non-exclusive. This provides WOA with a degree of contractual protection over the quality of Univar's market development activity.

The Lupin Protein Opportunity in China

Lupin is a legume native to Australia that carries a distinctive nutritional profile, including high protein content, low glycaemic index and no requirement for genetic modification. In the context of China's expanding plant-based food and beverage sector, lupin protein isolate is positioned as a functional ingredient with potential applications in dairy alternatives, meat substitutes, baked goods and nutrition products. The global plant-based protein market has attracted considerable Investment over the past several years, driven by consumer interest in sustainability and health-focused diets, though the market has also experienced significant Demand normalisation following the initial growth period.

Sector Context

Australian agricultural biotechnology companies pursuing ingredient plays in China face a specific set of structural challenges, including the need to navigate regulatory approval processes, establish reliable supply chains and build distribution partnerships capable of reaching a fragmented food and beverage manufacturing sector. The contract manufacturing transition WOA is managing reflects a broader pattern among small ingredient companies of exiting capital-intensive production and focusing on intellectual property, formulation expertise and commercial relationships. The success of this model depends heavily on securing manufacturing partners that can deliver consistent quality at competitive cost.

Risks

The agreement has no immediate financial impact, and revenue will only arise once commercial supply is restored and pricing is agreed. The transition to contract manufacturing introduces execution risk, particularly around quality consistency and production timing. The extended term to 2028 provides WOA with runway, but also extends the period of commercial uncertainty. There is no guarantee that any of the four prospective contract manufacturing partners will proceed to a preferred partner arrangement, or that the agreed commercial terms will support a viable Margin structure.

What to Watch Next

The appointment of a preferred contract manufacturing partner is the next material milestone for WOA's commercial trajectory. Once a partner is selected and commercial quantities of product are confirmed as available, the 12-month window for Univar's 50-tonne minimum purchase commitment will commence. Updates on framework agreement progress and any further regulatory or supply chain developments in China will also be significant for assessing the timeline to first revenue under the extended arrangement.